Search results
Results From The WOW.Com Content Network
Though CLIA does specify minimum retention periods, it does not explicitly specify which entity maintains ownership of the specimen while it is being retained and after the retention period has passed.The US currently does not have well-defined federal regulations regarding the ownership and utilization of physical human tissue specimens, their ...
Original file (825 × 1,275 pixels, file size: 1.11 MB, MIME type: application/pdf, 12 pages) This is a file from the Wikimedia Commons . Information from its description page there is shown below.
Original file (1,650 × 1,275 pixels, file size: 523 KB, MIME type: application/pdf, 2 pages) This is a file from the Wikimedia Commons . Information from its description page there is shown below.
In 1971, CLASP determined that a comprehensive book on quality assurance would be useful for laboratory personnel faced with new CLIA guidelines. A task force was established with Inhorn serving as chair, and a meeting was held at CDC in March 1974 to determine the outline of a book consisting of 5 general chapters on QA and 15 chapters on ...
Original file (562 × 1,275 pixels, file size: 201 KB, MIME type: application/pdf, 3 pages) This is a file from the Wikimedia Commons . Information from its description page there is shown below.
The Individualized Quality Control Plan (IQCP) is a quality management system under the US Clinical Laboratory Improvement Amendments (CLIA) federal regulatory standards. It is designed to enable regulated medical laboratories to manage the frequency of their quality control. [1] [2]
CLSI provides direct assistance in Sub-Saharan Africa to combat HIV/AIDS and other infectious diseases. With grants from the US-based PEPFAR (President's Emergency Plan for AIDS Relief) program administered by a cooperative agreement from the Centers for Disease Control and Prevention (CDC) and the National Institute of Allergy and Infectious Diseases (NIAID), CLSI has been actively involved ...
Legislative guidelines are provided under CLIA 88 (Clinical Laboratory Improvement Amendments) which regulates Medical Laboratory testing and personnel. The accrediting body in Australia is NATA, where all laboratories must be NATA accredited to receive payment from Medicare.